[
    [
        {
            "time": "",
            "original_text": "健帆生物：有计划进入血液透析领域，暂不考虑对同行并购",
            "features": {
                "keywords": [
                    "健帆生物",
                    "血液透析",
                    "计划",
                    "并购"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "健帆生物：有计划进入血液透析领域，暂不考虑对同行并购",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[买入评级] 健帆生物(300529)中报点评：业绩稳健高速增长 费用端略影响利润",
            "features": {
                "keywords": [
                    "买入评级",
                    "健帆生物",
                    "中报",
                    "业绩增长",
                    "费用端",
                    "利润"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级] 健舟生物(300529)中报点评：业绩稳健高速增长 费用端略影响利润",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]